As TOP1-targetd therapies are extensively used for a variety of cancers and second-generation TOP1 inhibitors are being developed4, insights from our study may be relevant to other cancers treated with TOP1 inhibitors such as ovarian and small cell lung cancers. This evidence concerns the gene TOP1 and cancer.